Platform Technology Partners Geron Corp Transaction History
Platform Technology Partners
- $284 Million
- Q2 2024
A detailed history of Platform Technology Partners transactions in Geron Corp stock. As of the latest transaction made, Platform Technology Partners holds 10,100 shares of GERN stock, worth $43,530. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,100
Previous 10,100
-0.0%
Holding current value
$43,530
Previous $21,000
100.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
258Shares Held
448MCall Options Held
1.91MPut Options Held
897K-
Black Rock Inc. New York, NY46.6MShares$201 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA46.2MShares$199 Million2.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.9MShares$138 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$117 Million17.06% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y923.9MShares$103 Million12.26% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.63B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...